By Catherine Eckford2025-09-29T12:25:59
The deal will support the biotech in its plans to advance bispecific antibody petosemtamab in multiple oncology indications.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-16T10:59:00Z
2026-06-15T07:55:00Z
Sponsored by Octave, By Adam Cross
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-06-26T08:43:00
Sponsored by Uniphar, By Tom Smith (Uniphar)
2026-06-15T07:55:00
Sponsored by Octave, By Adam Cross
2025-09-19T15:52:00
Sponsored by Sanner, By Uwe Raupbach (Sanner)
2025-12-11T13:32:00
Sponsored by Hexagon
Site powered by Webvision Cloud